Optimal Site of Administration for Continuous Wound Infusion After Cesarean Section
Evaluation of Optimal Anatomical Layer for Continuous Wound Infusion of Local Anesthetics Combined With NSAIDs Through a Multiorifice Catheter for Postoperative Pain Intensity After Elective Cesarean Delivery
1 other identifier
interventional
56
1 country
1
Brief Summary
The purpose of this randomized double-blind study is to evaluate in which anatomical layer (AF versus BF) continuous wound infusion of local anesthetics combined with NSAIDs through a multiorifice catheter has the best effectiveness during the first 48 hours on postoperative pain intensity after elective cesarean delivery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Oct 2007
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 12, 2010
CompletedFirst Posted
Study publicly available on registry
July 13, 2010
CompletedJuly 13, 2010
September 1, 2007
11 months
July 12, 2010
July 12, 2010
Conditions
Outcome Measures
Primary Outcomes (1)
Cumulative intravenous morphine consumption
48 hours
Secondary Outcomes (2)
Postoperative pain intensity at rest and mobilization
admission, 3,6,12,24,36,48h
adverse effects (nausea, vomiting, itching, sedation)
Study Arms (2)
Continuous wound infusion above the fascia
ACTIVE COMPARATORContinuous wound infusion below the fascia
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- elective Cesarean Section under spinal anesthesia over37 weeks' gestation
You may not qualify if:
- allergy to NSAIDs
- ASA III or higher
- refusal to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Cochin
Paris, 75014, France
Related Publications (1)
Rackelboom T, Strat SL, Silvera S, Schmitz T, Bassot A, Goffinet F, Ozier Y, Beaussier M, Mignon A. Improving continuous wound infusion effectiveness for postoperative analgesia after cesarean delivery: a randomized controlled trial. Obstet Gynecol. 2010 Oct;116(4):893-900. doi: 10.1097/AOG.0b013e3181f38ac6.
PMID: 20859153DERIVED
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 12, 2010
First Posted
July 13, 2010
Study Start
October 1, 2007
Primary Completion
September 1, 2008
Study Completion
December 1, 2008
Last Updated
July 13, 2010
Record last verified: 2007-09